Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arixtra vs MCS in Arthroplasty
NCT01809054Phase 4Completed
- Sponsor
- LifeBridge Health
- Start
- Apr 2012
- Primary completion
- Feb 2013
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 4 trial of fondaparinux in deep vein thrombosis (DVT), sponsored by LifeBridge Health. Started Apr 2012; status: completed.
02
Drugs
fondaparinux
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT01809054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01809054.